http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0905142-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5318709ebf1fa2152a71cb8513c2dd73
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4743
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02
filingDate 1998-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2002-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17f3e20610b88d2cd796aec2f9bd3bc8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80c36015d5eda5d0bded5b9890836f28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_613b9d148418d934e10b7716722b55f8
publicationDate 2002-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0905142-B1
titleOfInvention Inhibitors against prostate-specific antigen
abstract According to the present invention, there are provided inhibitors against prostate-specific antigen which comprise as a minimum unit a peptide consisting of Gly-Phe-Tyr-Lys-Lys-Lys-Gln-Ser-Arg, and such inhibitors can be expected to constitute a therapeutic drug against prostate carcinoma and prostate hyperplasia.
priorityDate 1997-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7708
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35002
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID719444
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136035172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128085802
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226830077
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129545319
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO97398
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6DT45
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25048
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID354
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128884591
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4428483
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP33619
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403079
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID408211
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24484
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16009
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6338045
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226403335
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398949
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID292872
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10902
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393519
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424856
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36339
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22618
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424855
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66710178

Total number of triples: 56.